156 related articles for article (PubMed ID: 22490574)
41. Neoadjuvant chemotherapy with FOLFOX: improved outcomes in Chinese patients with locally advanced gastric cancer.
Li ZY; Koh CE; Bu ZD; Wu AW; Zhang LH; Wu XJ; Wu Q; Zong XL; Ren H; Tang L; Zhang XP; Li JY; Hu Y; Shen L; Ji JF
J Surg Oncol; 2012 Jun; 105(8):793-9. PubMed ID: 22189752
[TBL] [Abstract][Full Text] [Related]
42. A pilot study of an individualized comprehensive treatment for advanced gastric cancer with para-aortic lymph node metastasis.
He Q; Ma L; Li Y; Li G
BMC Gastroenterol; 2016 Jan; 16():8. PubMed ID: 26782354
[TBL] [Abstract][Full Text] [Related]
43. [Efficacy of neoadjuvant chemotherpy in patients with locally advanced gastric cancer].
Wang Y; Liu TS; Zhuang RY; Cui YH; Wang ZM; Yu YY; Hou J; Sun YH; Shen KT; Shen ZB
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Feb; 16(2):166-9. PubMed ID: 23446480
[TBL] [Abstract][Full Text] [Related]
44. Phase II trial of paclitaxel and cisplatin as neoadjuvant chemotherapy for locally advanced gastric cancer.
Tsuburaya A; Nagata N; Cho H; Hirabayashi N; Kobayashi M; Kojima H; Munakata Y; Fukushima R; Kameda Y; Shimoda T; Oba K; Sakamoto J
Cancer Chemother Pharmacol; 2013 May; 71(5):1309-14. PubMed ID: 23463482
[TBL] [Abstract][Full Text] [Related]
45. Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: a University of Southern California pilot program.
Leichman L; Silberman H; Leichman CG; Spears CP; Ray M; Muggia FM; Kiyabu M; Radin R; Laine L; Stain S
J Clin Oncol; 1992 Dec; 10(12):1933-42. PubMed ID: 1453207
[TBL] [Abstract][Full Text] [Related]
46. Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma.
Ajani JA; Mayer RJ; Ota DM; Steele GD; Evans D; Roh M; Sugarbaker DJ; Dumas P; Gray C; Vena DA
J Natl Cancer Inst; 1993 Nov; 85(22):1839-44. PubMed ID: 8230264
[TBL] [Abstract][Full Text] [Related]
47. Resection after neoadjuvant therapy for locally advanced, "unresectable" pancreatic cancer.
Strobel O; Berens V; Hinz U; Hartwig W; Hackert T; Bergmann F; Debus J; Jäger D; Büchler MW; Werner J
Surgery; 2012 Sep; 152(3 Suppl 1):S33-42. PubMed ID: 22770956
[TBL] [Abstract][Full Text] [Related]
48. Perioperative chemotherapy in locally advanced gastric cancer. A retrospective study about 25 cases.
Ben Nasr S; Ayadi M; Bahloul R; Guesmi S; Allani B; Chrait N; Rifi H; Rais H; Mezlini A
Tunis Med; 2015 Apr; 93(4):228-30. PubMed ID: 26375739
[TBL] [Abstract][Full Text] [Related]
49. Low toxic neoadjuvant cisplatin, 5-fluorouracil and folinic acid in locally advanced gastric cancer yields high R-0 resection rate.
Menges M; Schmidt C; Lindemann W; Ridwelski K; Pueschel W; Jüngling B; Feifel G; Schilling M; Stallmach A; Zeitz M
J Cancer Res Clin Oncol; 2003 Jul; 129(7):423-9. PubMed ID: 12836016
[TBL] [Abstract][Full Text] [Related]
50. [Value of normalization window of tumor vasculature in neoadjuvant chemotherapy for patients with unresectable gastric cancer].
Zheng YB; Cao FY; Liu KJ; Gan HF; He XB; Tong SL
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Jan; 15(1):55-8. PubMed ID: 22287353
[TBL] [Abstract][Full Text] [Related]
51. Comparison of efficacy of different route of administration of chemotherapy on unresectable, advanced gastric cancer.
Zhang C; Li G; Fan C; Xu J; Cao J; Liu S; Li N
World J Surg Oncol; 2012 Aug; 10():162. PubMed ID: 22891660
[TBL] [Abstract][Full Text] [Related]
52. [Predictive and Prognostic significance of high-sensitivity modified Glasgow Prognostic Score (HS-mGPS) in advanced gastric cancer patients treated with neoadjuvant chemotherapy].
Cui Y; Li J; Cao YH; Liu MY; Shi ZX; Gao TH
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):195-200. PubMed ID: 28316218
[No Abstract] [Full Text] [Related]
53. Locally advanced unresectable gastric cancer successfully resected after neoadjuvant chemotherapy with FADE regimen.
Chung HC; Roh JK; Park YJ; Lee SI; Min JS; Lee JT; Lee KB; Kim BS
Yonsei Med J; 1990 Mar; 31(1):74-9. PubMed ID: 2346043
[TBL] [Abstract][Full Text] [Related]
54. [Conversion therapy of stage IV gastric cancer].
Tanizawa Y; Terashima M; Tokunaga M; Bando E; Kawamura T; Sugisawa N; Miki Y; Makuuchi R; Yamakawa Y; Kinugasa Y; Kanemoto H; Uesaka K; Yasui H
Gan To Kagaku Ryoho; 2012 Dec; 39(13):2469-73. PubMed ID: 23235167
[TBL] [Abstract][Full Text] [Related]
55. Phase II study of sequential high-dose methotrexate and fluorouracil combined with doxorubicin as a neoadjuvant chemotherapy for scirrhous gastric cancer.
Takahashi S; Kinoshita T; Konishi M; Nakagouri T; Inoue K; Ono M; Sugitou M; Ohtsu A; Boku N; Yoshida S
Gastric Cancer; 2001; 4(4):192-7. PubMed ID: 11846062
[TBL] [Abstract][Full Text] [Related]
56. Endoscopic ultrasound in restaging and predicting pathological response for advanced gastric cancer patients after neoadjuvant chemotherapy.
Guo T; Yao F; Yang AM; Li XY; Zhong DR; Wu DS; Wu X; Lu XH
Asia Pac J Clin Oncol; 2014 Jun; 10(2):e28-32. PubMed ID: 23279745
[TBL] [Abstract][Full Text] [Related]
57. Preoperative chemotherapy of locally advanced gastric cancer.
Rougier P; Lasser P; Ducreux M; Mahjoubi M; Bognel C; Elias D
Ann Oncol; 1994; 5 Suppl 3():59-68. PubMed ID: 8204531
[TBL] [Abstract][Full Text] [Related]
58. [Effect of neoadjuvant chemotherapy on the postoperative pulmonary infection of patients with advanced gastric cancer].
Fan CG; Li GL
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jul; 14(7):503-5. PubMed ID: 21792758
[TBL] [Abstract][Full Text] [Related]
59. Etoposide in gastric cancer.
Macdonald JS; Havlin KA
Semin Oncol; 1992 Dec; 19(6 Suppl 13):59-62. PubMed ID: 1492227
[TBL] [Abstract][Full Text] [Related]
60. Histological indications of a favorable prognosis with far-advanced gastric carcinomas after preoperative chemotherapy.
Ninomiya Y; Yanagisawa A; Kato Y; Kitagawa T; Ishihara S; Nakajima T
J Cancer Res Clin Oncol; 1999 Dec; 125(12):699-706. PubMed ID: 10592104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
